News First malaria drug for newborns and young infants cleared A new formulation of Novartis' antimalarial Coartem has become the first medicine to be approved for use in very young children.
News Medical groups sue RFK Jr over COVID-19 policies Medical groups have sued HHS Secretary Robert F Kennedy Jr for removing healthy children and pregnant women from COVID-19 shot recommendations.
News Charities call for shake-up in UK rare disease R&D LifeArc and Genetics Alliance UK have issued a call to the government to remove obstacles impeding R&D into rare diseases.
News Trump signs Medicaid-slashing budget into law Trump's One Big Beautiful Bill Act is signed into law, and commentators are gauging its impact on healthcare insurance coverage.
News UK pharma has concerns about the new NHS 10-year plan The ABPI is worried about investment in medicines and moves that could limit patient and doctor treatment choice in the NHS 10-year plan.
News The NHS 10 Year Plan arrives – what are the highlights? After months of preparation and a drip-feed of some of its key features, the UK government has raised the curtain on its new 10-year plan for the NHS.
News European Commission approves 2nd IPCEI to sum of €403m The European Commission has approved, under EU State aid rules, the second health-related IPCEI to support innovations in medical devices.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face